Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Relation between EDSS and monosymptomatic or polysymptomatic onset in clinical manifestations of multiple sclerosis in Babol, northern Iran.
Comparing two conditions of administering the six-minute walk test in people with multiple sclerosis.
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
The immunogenetics of multiple sclerosis: A comprehensive review.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
Treatment of chronic inflammatory polyneuropathy may improve associated hearing loss: A case report and a review of the literature.
How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
Diagnosis and classification of autoimmune optic neuropathy.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.
Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?
Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis-a computational approach.
Targeting IL-10 in Auto-immune Diseases.
Teriflunomide : a novel oral treatment for relapsing multiple sclerosis.
Alemtuzumab and multiple sclerosis: Is it safe?
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device.
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation.
New treatments for multiple sclerosis: at what long-term risk?
Supporting work for people with multiple sclerosis.
Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.
Moving to fingolimod from natalizumab in multiple sclerosis-reply.

Pages